IDH2 and angioimmunoblastic T-cell lymphoma: IDH2 mutations were also specifically identified in the tumor-cell-enriched cells, suggesting that IDH2 mutations are also tumor-cell-specific events in AITL, although the number of samples was not large enough to allow a definite conclusion.